KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $189.44 $217.57 Friday, 26th Apr 2024 BIIB stock ended at $208.90. This is 3.18% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.89% from a day low at $199.10 to a day high of $210.82.
90 days $189.44 $251.99
52 weeks $189.44 $319.76

Historical Biogen Inc. prices

Date Open High Low Close Volume
Apr 11, 2016 $271.57 $272.98 $264.21 $265.19 1 884 992
Apr 08, 2016 $275.00 $275.16 $267.33 $270.83 2 132 368
Apr 07, 2016 $278.03 $280.70 $271.15 $273.04 1 974 603
Apr 06, 2016 $266.33 $280.58 $266.17 $279.57 2 964 097
Apr 05, 2016 $262.28 $267.75 $262.15 $265.62 1 700 595
Apr 04, 2016 $260.79 $266.00 $260.04 $264.01 2 409 937
Apr 01, 2016 $258.83 $261.96 $257.50 $260.54 2 153 967
Mar 31, 2016 $255.07 $261.40 $254.19 $260.32 1 541 958
Mar 30, 2016 $256.04 $257.92 $252.63 $255.05 863 806
Mar 29, 2016 $251.68 $254.97 $246.74 $254.68 1 266 500
Mar 28, 2016 $255.05 $256.71 $251.45 $251.76 1 017 400
Mar 24, 2016 $253.79 $257.54 $251.13 $254.69 1 056 700
Mar 23, 2016 $257.00 $258.35 $253.59 $255.24 1 518 500
Mar 22, 2016 $252.70 $261.38 $252.20 $259.42 1 544 000
Mar 21, 2016 $249.52 $257.41 $247.01 $256.05 1 451 300
Mar 18, 2016 $247.83 $251.16 $243.21 $250.78 3 341 600
Mar 17, 2016 $250.00 $250.03 $242.25 $246.31 1 892 100
Mar 16, 2016 $250.42 $256.19 $247.61 $250.84 1 734 900
Mar 15, 2016 $257.47 $257.92 $248.54 $250.33 1 944 300
Mar 14, 2016 $258.91 $259.89 $256.90 $257.77 1 241 700
Mar 11, 2016 $255.98 $260.04 $255.10 $259.74 1 749 900
Mar 10, 2016 $257.00 $260.57 $251.00 $251.97 1 962 100
Mar 09, 2016 $261.26 $263.28 $252.38 $255.66 1 888 300
Mar 08, 2016 $267.24 $269.02 $260.78 $261.28 1 492 300
Mar 07, 2016 $262.14 $272.44 $261.20 $269.52 1 678 700
Click to get the best stock tips daily for free!

About Biogen Inc.

Biogen. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad... BIIB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT